Stock listing
TPEx:6976 Acepodia, Inc. (育世博-KY) 股價
Follow Acepodia, Inc. into a list and get an email when it puts out news.
Share price · TPEX:6976
$9.20 TWD -0.80 (-8.0%)
Close on Nov 20, 2026
- Day range
- $8.45 – $10.05 TWDNov 20, 2026
- Volume
- 676,075 sharesNov 20, 2026
- Market cap
- $5.36B TWDAt the close on Nov 20, 2026 · price × 582.9M shares outstanding
- 52-week range
- $8.45 – $17.40 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $6.09M TWDMedian day 399,989 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6976 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $9.20 | -0.80 | -8.0% | $10.00 | $10.05 | $8.45 | 676,075 | |
| $10.00 | -0.05 | -0.5% | $9.75 | $10.40 | $9.71 | 385,879 | |
| $10.05 | -0.70 | -6.5% | $10.75 | $10.85 | $9.85 | 961,525 | |
| $10.75 | -1.20 | -10.0% | $11.95 | $11.95 | $10.60 | 1,576,179 | |
| $11.95 | +0.05 | +0.4% | $11.90 | $11.95 | $11.60 | 141,577 | |
| $11.90 | -0.10 | -0.8% | $12.00 | $12.00 | $11.60 | 189,918 | |
| $12.00 | -0.10 | -0.8% | $11.85 | $12.20 | $11.85 | 117,235 | |
| $12.10 | -0.25 | -2.0% | $12.35 | $12.40 | $11.80 | 210,204 | |
| $12.35 | +0.40 | +3.3% | $12.00 | $12.45 | $11.85 | 408,307 | |
| $11.95 | -0.30 | -2.4% | $12.25 | $12.25 | $11.40 | 569,245 | |
| $12.25 | -0.50 | -3.9% | $12.35 | $12.75 | $12.05 | 512,482 | |
| $12.75 | +0.30 | +2.4% | $12.30 | $13.00 | $12.30 | 260,461 | |
| $12.45 | -0.30 | -2.4% | $13.15 | $13.15 | $12.20 | 442,375 | |
| $12.75 | -0.05 | -0.4% | $13.15 | $13.15 | $12.75 | 182,911 | |
| $12.80 | -0.55 | -4.1% | $13.35 | $13.35 | $12.75 | 221,712 | |
| $13.35 | +0.35 | +2.7% | $13.05 | $13.45 | $13.00 | 216,762 | |
| $13.00 | -0.05 | -0.4% | $12.80 | $13.10 | $12.60 | 301,655 | |
| $13.05 | -0.30 | -2.2% | $13.15 | $13.35 | $12.85 | 472,653 | |
| $13.35 | 0.00 | 0.0% | $13.35 | $13.35 | $13.35 | 0 | |
| $13.35 | +0.10 | +0.8% | $13.40 | $13.45 | $13.15 | 384,641 | |
| $13.25 | -0.10 | -0.7% | $13.45 | $13.45 | $13.20 | 333,421 | |
| $13.35 | +0.35 | +2.7% | $13.25 | $13.45 | $13.00 | 651,063 | |
| $13.00 | -0.15 | -1.1% | $13.00 | $13.35 | $12.90 | 501,255 | |
| $13.15 | -0.05 | -0.4% | $13.20 | $13.45 | $13.15 | 230,807 | |
| $13.20 | -0.10 | -0.8% | $13.35 | $13.45 | $13.00 | 693,669 | |
| $13.30 | 0.00 | 0.0% | $13.15 | $13.45 | $13.15 | 247,504 | |
| $13.30 | +0.05 | +0.4% | $13.45 | $13.45 | $13.10 | 463,704 | |
| $13.25 | -0.15 | -1.1% | $13.60 | $13.60 | $13.15 | 634,333 | |
| $13.40 | -0.10 | -0.7% | $13.55 | $13.55 | $13.20 | 527,630 | |
| $13.50 | +0.35 | +2.7% | $13.50 | $13.55 | $13.10 | 892,270 | |
| $13.15 | +0.20 | +1.5% | $13.10 | $13.55 | $12.90 | 1,294,156 | |
| $12.95 | +0.15 | +1.2% | $12.85 | $13.05 | $12.65 | 777,010 | |
| $12.80 | +0.15 | +1.2% | $12.85 | $12.95 | $12.65 | 357,200 | |
| $12.65 | -0.20 | -1.6% | $12.95 | $12.95 | $12.65 | 242,808 | |
| $12.85 | -0.05 | -0.4% | $13.00 | $13.00 | $12.65 | 453,315 | |
| $12.90 | +0.05 | +0.4% | $12.90 | $13.40 | $12.80 | 545,903 | |
| $12.85 | -0.15 | -1.2% | $13.10 | $13.10 | $12.70 | 329,205 | |
| $13.00 | +0.35 | +2.8% | $12.80 | $13.15 | $12.75 | 406,825 | |
| $12.65 | -0.45 | -3.4% | $13.15 | $13.15 | $12.50 | 1,083,982 | |
| $13.10 | 0.00 | 0.0% | $13.30 | $13.35 | $12.95 | 393,153 | |
| $13.10 | -0.35 | -2.6% | $13.45 | $13.45 | $12.95 | 779,413 | |
| $13.45 | +0.40 | +3.1% | $13.10 | $13.85 | $12.95 | 872,323 | |
| $13.05 | +0.50 | +4.0% | $12.70 | $13.30 | $12.65 | 686,487 | |
| $12.55 | -0.05 | -0.4% | $12.60 | $12.75 | $12.30 | 415,612 | |
| $12.60 | +0.25 | +2.0% | $12.45 | $12.75 | $12.45 | 492,248 | |
| $12.35 | -0.30 | -2.4% | $12.75 | $12.75 | $12.25 | 239,596 | |
| $12.65 | +0.05 | +0.4% | $12.45 | $12.80 | $12.30 | 358,662 | |
| $12.60 | +0.10 | +0.8% | $12.60 | $12.65 | $12.35 | 375,533 | |
| $12.50 | -0.65 | -4.9% | $13.35 | $13.35 | $12.15 | 556,979 | |
| $13.15 | +1.05 | +8.7% | $11.95 | $13.90 | $11.95 | 2,317,679 | |
| $12.10 | +0.10 | +0.8% | $12.00 | $12.15 | $11.65 | 360,846 | |
| $12.00 | +0.15 | +1.3% | $12.00 | $12.05 | $11.65 | 417,466 | |
| $11.85 | -0.10 | -0.8% | $11.95 | $11.95 | $11.75 | 435,108 | |
| $11.95 | 0.00 | 0.0% | $11.85 | $11.95 | $11.80 | 208,204 | |
| $11.95 | -0.10 | -0.8% | $11.85 | $12.05 | $11.75 | 367,006 | |
| $12.05 | +0.05 | +0.4% | $11.75 | $12.20 | $11.65 | 280,160 | |
| $12.00 | +0.20 | +1.7% | $11.70 | $12.35 | $11.70 | 325,157 | |
| $11.80 | -0.25 | -2.1% | $12.05 | $12.05 | $11.70 | 188,354 | |
| $12.05 | -0.15 | -1.2% | $12.20 | $12.20 | $11.65 | 248,059 | |
| $12.20 | +0.15 | +1.2% | $11.95 | $12.30 | $11.65 | 616,464 | |
| $12.05 | +0.05 | +0.4% | $11.80 | $12.05 | $11.80 | 204,759 | |
| $12.00 | 0.00 | 0.0% | $11.95 | $12.00 | $11.75 | 163,459 |
- Ticker
- TPEx:6976
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
What changed lately
Latest news release · Sep 4, 2026
Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate
Latest news
Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate
Sep 4, 2026
Closed $13.15 (+8.7%) on Sep 7, 2026
Acepodia, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 2 in the last 12 months · 2 in all · newest Sep 4, 2026 · oldest 2026
Valuation
EV/sales 10,415× against a median of 15.5×: the highest of 9 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.93B TWD
- P/E
- Loss
- EV/sales
- 10,415×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.1×
- Gross margin
- 65.4%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Acepodia, Inc. · TPEX:6976 | US$162.7M | US$58.45M | n/a | 10,415× | n/a | 1.1× | n/a | 0.0× | n/a |
| Guangzhou Innogen Pharmaceutical Group Co Ltd Class H · HKEX:2591 | US$170.8M | US$39.93M | n/a | 2.1× | n/a | 1.2× | −259.6% | 0.2× | n/a |
| Entrada Therapeutics, Inc. · NASDAQ:TRDA | US$170.3M | US$24.60M | n/a | 6.2× | n/a | 0.9× | n/a | 0.2× | 1.43 |
| SinoMab Bioscience Ltd. · HKEX:3681 | US$166.3M | US$172.4M | n/a | n/a | n/a | 3.1× | n/a | 0.7× | n/a |
| Prestige BioPharma Limited · KRX:950210 | US$164.7M | US$131.9M | n/a | 6.8× | n/a | 0.5× | −350.9% | 0.1× | n/a |
| TaiGen Biopharmaceuticals Holdings Limited · TPEX:4157 | US$161.1M | US$133.3M | 34.2× | 17.1× | 46.8× | 5.2× | 60.5% | 0.0× | n/a |
| Baijin Life Science Holdings Limited · HKEX:1466 | US$160.0M | US$158.1M | n/a | 13.9× | n/a | 6.8× | −42.4% | 0.1× | n/a |
| ImmuneOncia Therapeutics Inc. · KRX:424870 | US$159.0M | US$89.79M | n/a | n/a | n/a | 2.1× | n/a | 0.0× | n/a |
| Jiangsu Recbio Technology Co., Ltd. Class H · HKEX:2179 | US$157.3M | US$230.2M | n/a | 124× | n/a | 2.1× | n/a | 1.4× | n/a |
| BioVersys AG · SIX:BIOV | US$154.1M | US$97.45M | n/a | 102× | n/a | 2.9× | n/a | 0.5× | n/a |
| InflaRx N.V. · NASDAQ:IFRX | US$153.3M | US$135.7M | n/a | 4,215× | n/a | 19.5× | n/a | 0.0× | 1.61 |
| Median of the others | US$160.5M | US$132.6M | 34.2× | 15.5× | 46.8× | 2.5× | −151.0% | 0.2× | 1.52 |
Team and board
Officers
| Officer | Role |
|---|---|
| Sonny Hsiao | CEO |
Board
| Director | Role |
|---|---|
| Patrick Yang | Chairman of the Board |
| Carolyn Bertozzi | Nominated Board Member |
| Sonny Hsiao | CEO |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 185.0K | 427.0K | 16.6M | 0 | 0 | |
| Cost of revenue | 64.0K | 149.0K | 0 | |||
| Gross profit | 121.0K | 278.0K | 16.6M | |||
| Research and development | 806.8M | 612.7M | 310.9M | 341.6M | 303.5M | 115.5M |
| Selling, general and administrative | 162.6M | 145.5M | 141.6M | 176.0M | 173.8M | 34.1M |
| Operating income | -969.2M | -757.9M | -811.7M | -1.41B | -477.3M | -149.6M |
| Depreciation and amortization | 115.2M | 80.7M | 47.2M | 23.0M | 12.1M | 4.29M |
| EBITDA | -854.0M | -677.2M | -764.5M | -1.39B | -465.2M | -145.4M |
| Interest expense | 6.01M | 6.49M | 4.84M | 1.51M | 798.0K | 60.0K |
| Income before tax | -763.3M | -473.0M | -816.5M | -1.41B | -878.5M | -455.0M |
| Income tax | 776.0K | -400.4M | -305.3M | |||
| Net income | -754.4M | -496.7M | -817.3M | -1.41B | -878.5M | -455.0M |
| Earnings per share, basic | -1.30 | -0.87 | -1.44 | -30.79 | -77.69 | -40.23 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 3.80B | 5.87B | 6.29B | 3.73B | 1.55B | 225.6M |
| Short-term investments | 262.3M | 2.21B | ||||
| Receivables | 0 | 122.0K | 0 | |||
| Current assets | 3.94B | 6.19B | 6.34B | 3.78B | 3.80B | 231.4M |
| Total assets | 5.83B | 6.82B | 6.82B | 3.87B | 3.90B | 253.2M |
| Current liabilities | 194.4M | 206.1M | 137.6M | 125.8M | 95.1M | 18.6M |
| Total debt | 273.8M | 52.4M | 53.8M | 6.95M | ||
| Total liabilities | 415.1M | 479.2M | 384.5M | 6.88B | 5.36B | 963.5M |
| Shareholders' equity | 5.42B | 6.34B | 6.43B | -3.01B | -1.46B | -710.2M |
| Shares outstanding | 582.2M | 573.7M | 567.0M | 45.9M | 11.3M | 11.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | -707.3M | -369.0M | -282.7M | -372.8M | -357.9M | -103.4M |
| Capital spending | -72.9M | -127.8M | -179.4M | -7.71M | -28.7M | -3.62M |
| Free cash flow | -780.2M | -496.8M | -462.1M | -380.5M | -386.6M | -107.0M |
| Cash from financing | 3.00B | -9.63M | 3.98B | -1.29M | ||
| Change in cash | -2.07B | -425.2M | 2.57B | 2.18B | 1.32B | -118.9M |
Cap table
Built by 6ix from Acepodia, Inc.’s releases
- Common shares
- 582,867,110
- Fully diluted
- 582,867,110
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 582,867,110 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 582,867,110 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Sonny Hsiao | CEO · Since at least Sep 4, 2026 |
Log in to ask 6ix AI your own questions about Acepodia, Inc.